Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Molecular and Genetic Insights for Personalized Treatment of Non-Muscle-Invasive Bladder Cancer.
Journal: The Urologic clinics of North America
Published: June 26, 2026
The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) study.
Journal: BJU international
Published: June 10, 2026
Genomic analysis of BCG unresponsive non-muscle-invasive bladder cancer identifies drivers of sensitivity to intravesical Gemcitabine/Docetaxel.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2026
Noninvasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRI.
Journal: The Journal of urology
Published: April 28, 2026
89Zr-girentuximab PET/CT Enables Noninvasive Assessment of Indeterminate Renal Masses and Metastatic Clear-Cell Renal Cell Carcinoma.
Journal: Pharmaceutics
Published: January 04, 2026
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 22, 2025
Prostate Cancer Risk and DNA Mismatch Repair Deficiency Among Lynch Syndrome Patients.
Journal: European urology open science
Published: November 21, 2025
Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate Cancer.
Journal: bioRxiv : the preprint server for biology
Published: June 06, 2025
Intracardiac Teratoma in a Patient With Nonseminomatous Germ Cell Tumor.
Journal: JACC. Case reports
Published: July 16, 2024
PSA density as a dynamic prognostic marker of biopsy grade progression during active surveillance.
Journal: Urologic oncology
Published: June 30, 2024
Last Updated: 09/26/2026